Cynthia J. Dieter - Mar 1, 2023 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Accounting Officer
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/3/2023, 04:34 PM
Previous filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Tax liability $0 -880 -2.86% $0.00 29.9K Mar 1, 2023 Direct F1
transaction NEO Common Stock Tax liability $0 -117 -0.39% $0.00 29.8K Mar 2, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 3.97K Mar 1, 2023 Common Stock 3.97K $28.35 Direct F3
holding NEO Stock Option (Right to Buy) 7.03K Mar 1, 2023 Common Stock 7.03K $53.17 Direct F4
holding NEO Stock Option (Right to Buy) 22.8K Mar 1, 2023 Common Stock 22.8K $21.41 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2023 vesting of restricted stock.
F2 Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2023 vesting of restricted stock.
F3 On June 22, 2020, Ms. Dieter was granted 3,968 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4 On March 2, 2021, Ms. Dieter was granted 7,034 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F5 On March 1, 2022, Ms. Dieter was granted 22,805 stock options. These options vest ratably over the first four anniversary dates of the grant date.